专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011150883A3 METHOD AND DEVICE FOR TERMINAL BATCH UPGRADING 审中-公开
标题翻译：用于终端批量升级的方法和装置
公开(公告)号：WO2011150883A3
公开(公告)日：2012-05-24
申请号：PCT/CN2011076199
申请日：2011-06-23
申请人： HUAWEI DEVICE CO LTD , WANG JING , HAN WEI , DONG NIAN , ZHU GUANGZE
发明人： WANG JING , HAN WEI , DONG NIAN , ZHU GUANGZE
IPC分类号： H04L12/24 , H04L29/06 , H04L29/12
CPC分类号： H04L41/082
摘要： The embodiments of the present invention disclose a method and device for terminal batch upgrading. The method includes: assigning different Internet Protocol (IP) addresses to different virtual network cards communicating with various terminals; binding respectively upgrade data packets, needing to be transmitted, with the various virtual network cards, or transmitting respectively maintenance IP address modification commands to the terminals communicating with the various virtual network cards, so that each terminal can modify its own maintenance IP address to a preset IP address separately, wherein the modified preset IP addresses of the various terminals are different; transmitting the upgrade data packets simultaneously to the various terminals via the different IP addresses of the various virtual network cards, so that the various terminals can fulfill the upgrading after receiving the upgrade data packets.
摘要翻译：本发明的实施例公开了一种用于终端批量升级的方法和装置。该方法包括：向与各种终端通信的不同虚拟网卡分配不同的因特网协议（IP）地址; 绑定分别升级需要与各种虚拟网卡进行传输的数据包，或者分别向与各种虚拟网卡通信的终端发送维护IP地址修改命令，以便每个终端可以将其自己的维护IP地址修改为预设IP地址，其中各个终端的修改的预设IP地址不同; 通过各种虚拟网卡的不同IP地址将升级数据包同时发送到各个终端，使得各种终端可以在接收到升级数据包之后实现升级。

2. 发明申请

WO2011157173A3 ROUTE DECISION METHOD, CONTENT DELIVERY APPARATUS AND CONTENT DELIVERY NETWORK INTERCONNECTION SYSTEM 审中-公开
标题翻译：路由决策方法，内容传送装置和内容传送网络互连系统
公开(公告)号：WO2011157173A3
公开(公告)日：2012-05-03
申请号：PCT/CN2011075300
申请日：2011-06-03
申请人： HUAWEI TECH CO LTD , HE XIAOYAN , LI JINCHENG , WANG JING
发明人： HE XIAOYAN , LI JINCHENG , WANG JING
IPC分类号： H04L12/56
CPC分类号： H04L43/0876 , H04L45/125 , H04L67/1029 , H04L67/2814 , H04N7/17327 , H04N7/17336
摘要： Embodiments of the present invention relate to a route decision method, content delivery apparatus and Content Delivery Network (CDN) interconnection system. The route decision method includes: receiving a notification message sent from a downstream CDN and determining the total quantity of current services according to the notification message; performing a route decision for a user request to be forwarded according to the total quantity of the current services and a total quantity threshold of the services; and the total quantity threshold of the services is the upper limit of the services provided by the downstream CDN for an upstream CDN, wherein the upper limit is set by the downstream CDN. The embodiments of the present invention improve the accuracy of selecting a downstream CDN by an upstream CDN for the user request to be forwarded, thus improving the efficiency of the route decision.
摘要翻译：本发明的实施例涉及一种路由决定方法，内容传送装置和内容传送网络（CDN）互连系统。路由决定方法包括：接收从下游CDN发送的通知消息，并根据该通知消息确定当前业务的总数量; 根据当前业务的总量和业务的总量阈值，对用户请求转发的路由决定; 服务的总量阈值是下游CDN为上游CDN提供的服务的上限，其中上限由下游CDN设置。本发明的实施例提高了由用户请求转发的上游CDN选择下行CDN的准确性，从而提高了路由决策的效率。

3. 发明申请

WO2012003482A2 HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (II) 审中-公开
标题翻译：空穴传输组合物及相关装置和方法（II）
公开(公告)号：WO2012003482A2
公开(公告)日：2012-01-05
申请号：PCT/US2011042861
申请日：2011-07-01
申请人： PLEXTRONICS INC , BROWN CHRISTOPHER T , CHOPRA NEETU , KNITTEL CHRISTOPHER R , MATHAI MATHEW , SESHADRI VENKATARAMANAN , WANG JING , WOODWORTH BRIAN
发明人： BROWN CHRISTOPHER T , CHOPRA NEETU , KNITTEL CHRISTOPHER R , MATHAI MATHEW , SESHADRI VENKATARAMANAN , WANG JING , WOODWORTH BRIAN
IPC分类号： C08L65/00
CPC分类号： H01L51/0007 , C07D403/00 , C08F226/02 , C08G73/0206 , C08G2261/222 , C08G2261/312 , C08G2261/3142 , C08G2261/3162 , C08G2261/364 , C08G2261/512 , C08G2261/76 , C09B57/008 , C09B69/109 , C09D11/102 , C09D11/106 , C09D11/52 , H01B1/12 , H01L51/0003 , H01L51/0039 , H01L51/0043 , H01L51/0059 , H01L51/006 , H01L51/0074 , H01L51/5004 , H01L51/5056 , H01L2251/552
摘要： A composition comprising: at least one compound comprising a hole transporting core, wherein the core is covalently bonded to a first arylamine group and also covalently bonded to a second arylamine group different from the first, and wherein the compound is covalently bonded to at least one intractability group, wherein the intractability group is covalently bonded to the hole transporting core, the first arylamine group, the second arylamine group, or a combination thereof, and wherein the compound has a molecular weight of about 5,000 g/mole or less. Blended mixtures of arylamine compounds, including fluorene core compounds, can provide good film formation and stability when coated onto hole injection layers. Solution processing of OLEDs is a particularly important application.
摘要翻译： 1。一种组合物，其包含：至少一种包含空穴传输核心的化合物，其中所述核心与第一芳基胺基团共价键合并且还与不同于所述第一芳基胺基团的第二芳基胺基团共价键合，并且其中所述化合物共价键合至少一个其中难处理性基团共价键合到空穴输送核，第一芳胺基，第二芳胺基或它们的组合，并且其中所述化合物具有约5,000g / mol或更小的分子量。芳胺化合物（包括芴核化合物）的混合混合物在涂覆到空穴注入层上时可以提供良好的成膜和稳定性。 OLED的解决方案处理是特别重要的应用。

4. 发明申请

WO2007092713A3 MICROFLUIDIC SYSTEM AND METHOD FOR ANALYSIS OF GENE EXPRESSION IN CELL-CONTAINING SAMPLES AND DETECTION OF DISEASE 审中-公开
标题翻译：用于分析含细胞样本中基因表达的微流感系统和方法及疾病的检测
公开(公告)号：WO2007092713A3
公开(公告)日：2008-12-18
申请号：PCT/US2007061352
申请日：2007-01-31
申请人： UNIV PENNSYLVANIA , ZIOBER BARRY L , BAU HAIM H , MAUK MICHAEL G , CHEN ZONGYUAN , WANG JING
发明人： ZIOBER BARRY L , BAU HAIM H , MAUK MICHAEL G , CHEN ZONGYUAN , WANG JING
IPC分类号： B01D11/04 , B01L3/00 , C12M1/30 , C12M3/00 , C12Q1/00 , G01N1/18 , G01N9/30 , G01N15/06 , G01N21/00 , G01N21/75 , G01N31/00 , G01N33/00 , G01N33/48 , G01N33/53 , G01N33/536 , G01N33/543 , G01N33/551 , G01N33/553
CPC分类号： G01N33/574 , B01L3/502761 , B01L7/52 , B01L2200/0636 , B01L2200/0647 , B01L2300/0816 , B01L2300/0864 , B01L2300/1894 , B01L2400/043 , B01L2400/0487 , B01L2400/0677 , C12Q1/6886 , C12Q2600/158 , G01N33/54366 , G01N2333/70503 , G01N2800/52
摘要： Biomarkers for the detection of pre-cancer and cancer cells and a method for their detection at the point of care are disclosed. The system is comprised of an inexpensive, disposable microfluidic cassette for sample preparation; continuous-flow, magnetic-bead assisted cell sorting and cytometry; cell lysis; nucleic acid isolation and amplification, hybridization, quantification, and analysis. Typically, the disposable cassette will be used with a benchtop instrument platform that provides power, control and detection capabilities to the cassette. In one particular embodiment and application of the invention, the cell sorting is based on the selective binding of magnetic beads coated with an MCAP antibody to exfoliated precancerous and cancerous cells contained in saliva. The bead-labeled precancerous and cancerous cells are then separated from other saliva components using a magnetic field. Both labeled and unlabeled cells can be counted using integrated detectors of several types, including cell counters based on impedance measurements, and cytometers based on Coulter particle counter principles. The sorted sub-population of precancerous and cancerous cells are lysed, and the nucleic acids are isolated for gene assays and/or transcription profiling of the sorted sample subpopulation. In one embodiment of the invention, the cassette includes re verse- transcription polymerase chain reaction for nucleic acid detection and a hybridization array for gene identification. The devices, systems, modes of operation, and methods disclosed here are also applicable for cancer and other disease detection in other body fluids.
摘要翻译：公开了用于检测癌前和癌细胞的生物标志物及其在护理时检测的方法。该系统由用于样品制备的廉价的一次性微流控盒组成; 连续流动，磁珠辅助细胞分选和细胞计数; 细胞裂解; 核酸分离和扩增，杂交，定量和分析。通常，一次性盒式磁带将与台式仪器平台一起使用，该平台为磁带提供功率，控制和检测能力。在本发明的一个具体实施方案和应用中，细胞分选基于用MCAP抗体包被的磁珠与包含在唾液中的脱落的癌前和癌细胞的选择性结合。然后使用磁场将珠标记的癌前和癌细胞与其他唾液成分分离。可以使用几种类型的集成检测器（包括基于阻抗测量的细胞计数器）和基于Coulter粒子计数器原理的细胞计数器来计数标记和未标记的细胞。裂解癌前和癌细胞的分选亚群，分离核酸用于分选的样品亚群的基因测定和/或转录谱。在本发明的一个实施方案中，盒包括用于核酸检测的转录聚合酶链反应和用于基因鉴定的杂交阵列。本文公开的装置，系统，操作模式和方法也适用于其他体液中的癌症和其他疾病检测。

5. 发明申请

WO0149687A9 CYCLOHEXENE NUCLEIC ACIDS 审中-公开
标题翻译：环己烯核酸
公开(公告)号：WO0149687A9
公开(公告)日：2002-09-06
申请号：PCT/IB0002041
申请日：2000-12-27
申请人： LEUVEN K U RES & DEV , WANG JING , HERDEWIJN PIET
发明人： WANG JING , HERDEWIJN PIET
IPC分类号： G01N33/68 , A61K9/08 , A61K9/14 , A61K31/712 , A61P25/00 , A61P43/00 , C07D473/34 , C07H19/16 , C07H19/20 , C07H21/00 , C07H21/02 , C07H21/04 , C12N15/09 , A61K31/70
CPC分类号： C07H21/00 , C07D473/34
摘要： Replacement of the furanose moiety of, for example, DNA by a cyclohexene ring gives a new nucleic acid structure: cyclohexene nucleic acids or CeNA. Cyclohexene nucleic acids can be obtained by the classical phosphoramidite chemistry starting from protected cyclohexenyl nucleoside building blocks. Incorporation of cyclohexenyl nucleosides in a DNA chain increases the stability of a DNA/RNA hybrid, the complex formed between cyclohexenyl oligoadenylate and its DNA or RNA complement is of similar stability. CD and NMR studies indicate easy conformational adaptation of a cyclohexenyl nucleoside when incorporated in a natural nucleic acid structure. CeNA is stable against degradation in serum and a CeNA/RNA hybrid is able to activate E. Coli Rnase H, resulting in cleavage of the RNA strand.
摘要翻译：例如用环己烯环替代DNA的呋喃糖部分产生新的核酸结构：环己烯核酸或CeNA。环己烯核酸可以由经保护的环己烯基核苷结构单元开始的经典亚磷酰胺化学获得。将环己烯基核苷掺入DNA链增加了DNA / RNA杂合体的稳定性，环己烯基低聚腺苷酸与其DNA或RNA补体之间形成的复合物具有相似的稳定性。 CD和NMR研究表明，当掺入天然核酸结构时，环己烯基核苷容易构象适应。 CeNA对血清中的降解稳定并且CeNA / RNA杂合体能够激活大肠杆菌RNA酶H，导致RNA链的切割。

6. 发明申请

WO2012071469A2 HISTONE DEMETHYLASE INHIBITORS AND USES THEREOF FOR TREATMENT O F CANCER 审中-公开
标题翻译： HISTONE DEMETHYLASE抑制剂及其用于治疗的用途
公开(公告)号：WO2012071469A2
公开(公告)日：2012-05-31
申请号：PCT/US2011061954
申请日：2011-11-22
申请人： NEVADA CANCER INST , SHENZHEN GRADUATE SCHOOL OF PEKING UNIVERSITY , ZHANG HUI , YE TAO , QUAN JUNMIN , WANG JING
发明人： ZHANG HUI , YE TAO , QUAN JUNMIN , WANG JING
IPC分类号： C07D403/02 , A61K31/496
CPC分类号： C07D295/215 , A61K31/496 , C07D211/46 , C07D211/58 , C07D211/62
摘要： A compound of formula I: or a pharmaceutically acceptable salt, Ri is an optionally substituted heterocyclic group; R and R' are independently H, CH3, NO2, SO2N(CH3)2, SO2N((CH3)SO2), COOH, COOCH3, CO(N(CH3)), alkyl, alkenyl, alkynyl, aryl, aralkyl, cycloalkyl, heteroaryl, heterocycloalkyl, alkoxy, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, carboxylate, alkylcarbonyl, alkylaminocarbonyl, aralkylaminocarbonyl, alkenylaminocarbonyl, alkylcarbonyl, arylcarbonyl, aralkylcarbonyl, alkenylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylthiocarbonyl, trifluoromethyl, pentafluoroethyl, halogen, cyano, thio, amido, ether, ester, hydroxyl, hydroxyalkyl, saturated or unsaturated fatty acids, azido, phosphonamido, sulfonamido, lactam, phosphate, phosphonato, phosphinato, amino, acylamino, amidino, imino, guanidino, sulfhydryl, alkylthio, arylthio, thiocarboxylate, sulfates, alkylsulfinyl, sulfonato, sulfamoyl, sulfonamido, nitro, cyano, or azido; m and n are independently integers from 1 to 4; T, U, V, and Z are independently CH, N, or CR; L is NH, CH2, O, S, or SO2; X is N or CH; Y and Y' are independently O or S; and R3 is an optionally substituted aryl, heteroaryl, cycloalkyl, or heterocycloalkyl group.
摘要翻译：式I化合物或其药学上可接受的盐，R 1是任选取代的杂环基; R和R'独立地是H，CH 3，NO 2，SO 2 N（CH 3）2，SO 2 N（（CH 3）SO 2），COOH，COOCH 3，CO（N（CH 3）），烷基，烯基，炔基，芳基，芳烷基，环烷基，杂芳基，杂环烷基，烷氧基，烷基羰基氧基，芳基羰基氧基，烷氧基羰基氧基，芳氧基羰基氧基，羧酸酯，烷基羰基，烷基氨基羰基，芳烷基氨基羰基，烯基氨基羰基，烷基羰基，芳基羰基，芳烷基羰基，烯基羰基，烷氧羰基，氨基羰基，烷硫基羰基，三氟甲基，五氟乙基，卤素，氰基，醚，酯，羟基，羟基烷基，饱和或不饱和脂肪酸，叠氮基，酰基氨基，亚磺酰氨基，内酰胺，磷酸酯，膦酰基，次膦酸酯基，氨基，酰氨基，脒基，亚氨基，胍基，巯基，烷硫基，芳硫基，硫代羧酸酯，硫酸酯，烷基亚磺酰基，磺酸基，氨磺酰基，亚磺酰氨基，硝基，氰基或叠氮基; m和n独立地为1至4的整数; T，U，V和Z独立地为CH，N或CR; L是NH，CH 2，O，S或SO 2; X为N或CH; Y和Y'独立地为O或S; 并且R 3是任选取代的芳基，杂芳基，环烷基或杂环烷基。

7. 发明申请

WO2012021375A3 THE RECOVERY OF ALUMINA TRIHYDRATE DURING THE BAYER PROCESS USING CROSS-LINKED POLYSACCHARIDES 审中-公开
标题翻译：使用交联多糖在贝叶过程中恢复氧化铝三水合物
公开(公告)号：WO2012021375A3
公开(公告)日：2012-05-24
申请号：PCT/US2011046579
申请日：2011-08-04
申请人： NALCO CO , WANG JING , BODE HEINRICH E , LI XIAOJIN HARRY
发明人： WANG JING , BODE HEINRICH E , LI XIAOJIN HARRY
IPC分类号： C01F7/06 , B01D21/01 , C01F7/47
CPC分类号： C01F7/145 , C01F7/0653 , C01F7/148 , C01F7/47
摘要： The invention provides methods and compositions for improving the production of alumina hydrate. The invention involves adding one or more polysaccharides to liquor or slurry in the fluid circuit of the production process. The one or more polysaccharides can be a cross-linked polysaccharide (such as cross-linked dextran or cross-linked dihydroxypropyl cellulose). The various polysaccharides can impart a number of advantages including at least some of: greater flocculation effectiveness, increasing the maximum effective dosage, faster settling rate. The production process can be a Bayer process.
摘要翻译：本发明提供了改善水合氧化铝生产的方法和组合物。本发明涉及在生产过程的流体回路中向液体或浆料中加入一种或多种多糖。一种或多种多糖可以是交联的多糖（例如交联的葡聚糖或交联的二羟丙基纤维素）。各种多糖可以赋予许多优点，包括以下至少一些：更大的絮凝效果，增加最大有效剂量，更快的沉降速率。生产过程可以是拜耳过程。

8. 发明申请

WO2011100502A8 7-AMINOFUROPYRIDINE DERIVATIVES 审中-公开
标题翻译： 7-氨基脲衍生物
公开(公告)号：WO2011100502A8
公开(公告)日：2011-09-22
申请号：PCT/US2011024449
申请日：2011-02-11
申请人： OSI PHARMACEUTICALS LLC , HORNBERGER KEITH R , BERGER DAN M , CHEN XIN , CREW ANDREW P , DONG HANQING , KLEINBERG ANDREW , LI AN-HU , MA LIFU , MULVIHILL MARK J , PANICKER BIJOY , SIU KAM W , STEINIG ARNO G , TARRANT JAMES G , WANG JING , WENG QINGHUA , SANGEM RAJARAM , GUPTA RAMESH C
发明人： HORNBERGER KEITH R , BERGER DAN M , CHEN XIN , CREW ANDREW P , DONG HANQING , KLEINBERG ANDREW , LI AN-HU , MA LIFU , MULVIHILL MARK J , PANICKER BIJOY , SIU KAM W , STEINIG ARNO G , TARRANT JAMES G , WANG JING , WENG QINGHUA , SANGEM RAJARAM , GUPTA RAMESH C
IPC分类号： C07D491/048 , A61K31/4355 , A61P35/00
CPC分类号： C07D491/048
摘要： Compounds of Formula (1), as shown below and defined herein: pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by TAK1 or for which an appropriate TAK1 inhibitor is effective. This Abstract is not limiting of the invention.
摘要翻译：式（1）的化合物，如下文所定义：其药学上可接受的盐，合成，中间体，制剂及其治疗方法，包括治疗癌症，例如至少部分由TAK1驱动的肿瘤，或其中适当的TAK1抑制剂是有效的。本发明并不限于本发明。

9. 发明申请

WO2010059646A3 AMINOBENZENE COMPOSITIONS AND RELATED DEVICES AND METHODS 审中-公开
标题翻译：氨基苯组合物及相关装置和方法
公开(公告)号：WO2010059646A3
公开(公告)日：2010-07-29
申请号：PCT/US2009064857
申请日：2009-11-17
申请人： PLEXTRONICS INC , BROWN CHRISTOPHER T , SESHADRI VENKATARAMANAN , WANG JING
发明人： BROWN CHRISTOPHER T , SESHADRI VENKATARAMANAN , WANG JING
IPC分类号： C08G73/02 , C08G61/12 , H01B1/12 , H01L51/00 , H01L51/50
CPC分类号： H01B1/128 , C07C213/00 , C07C217/92 , C07D209/88 , C08G73/0246 , C08G73/0266 , C09B69/103 , C09B69/109 , H01L51/0035 , H01L51/5088 , Y02E10/549 , Y10T428/1005 , Y10T428/1055
摘要： Oligomers and/or polymers comprising a backbone comprising arylamine and fluorinated alkyleneoxy moieties which may be crosslinked. Ink formulations and devices can be formed from the oligomers or polymers, or corresponding monomers. Doped compositions can be formed. Charge injection and transport layers can be formed. Improved stability can be achieved in organic electronic devices such as OLEDs and OPVs.
摘要翻译：包含主链的低聚物和/或聚合物，所述主链包含可以交联的芳基胺和氟化亚烷基氧基部分。油墨制剂和装置可以由低聚物或聚合物或相应的单体形成。可以形成掺杂的组合物。电荷注入和传输层可以形成。在有机电子器件如OLED和OPV中可以实现稳定性的提高。

10. 发明申请

WO2006017124A3 OXYGEN/NITROGEN HETEROCYCLE INHIBITORS OF TYROSINE PHOSPHATASES 审中-公开
标题翻译：氧自由基的氧/氮杂环化合物抑制剂
公开(公告)号：WO2006017124A3
公开(公告)日：2009-04-09
申请号：PCT/US2005024130
申请日：2005-07-08
申请人： CENGENT THERAPEUTICS INC , CHERUVALLATH ZACCHARIA S , SEMPLE JOSEPH E , WANG JING , NUTT RUTH F , MYLVAGANAM SHANKARI
发明人： CHERUVALLATH ZACCHARIA S , SEMPLE JOSEPH E , WANG JING , NUTT RUTH F , MYLVAGANAM SHANKARI
IPC分类号： A61K31/42
CPC分类号： A61K31/4245 , C07D263/48 , C07D271/07 , C07D413/10 , C07F9/653 , C07F9/65312 , C07F9/65583
摘要： Compounds, pharmaceutical compositions, and methods for treating, preventing, or ameliorating symptoms associated with diseases such as diabetes, cancer, neurodegenerative diseases, and obesity are provided. The compounds and compositions inhibit protein tyrosine phosphatase enzymes, e.g., PTP-1B.
摘要翻译：提供了用于治疗，预防或改善与诸如糖尿病，癌症，神经变性疾病和肥胖症等疾病相关的症状的化合物，药物组合物和方法。化合物和组合物抑制蛋白酪氨酸磷酸酶，例如PTP-1B。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式